Pharma Focus Asia
KP - Choose our fully recyclable blister films

Cipher Pharmaceuticals Launches a Novel Bactericidal Topical Antibiotic Cream in Canada

Cipher Pharmaceuticals Inc announced the Canadian launch of OZANEX™ (ozenoxacin cream, 1%), a novel bactericidal topical antibiotic cream indicated for the treatment of impetigo in patients aged 2 months and older.

OZANEX can be used to cure one of the most common and contagious bacterial skin infections. It can be utilised as a new and important treatment alternative for skin infections.

The novel bactericidal topical antibiotic cream is capable to fulfill all unmet medical needs due to its effectiveness against a broad range of bacteria including sensitive and resistant bacteria such as MRSA.

OAZANEX has showcased excellent antibacterial activity against Streptococcus pyogenes and Staphylococcus aureus, including methicillin-resistant (MRSA) strains in two Phase III pivotal studies involving 875 adult and pediatric subjects.

It has shown short 5-day BID dosing regimen and bacteriological eradication as early as day three of treatment.

After conducting few tests, OZANEX was found to be negligibly absorbed, safe, and well-tolerated in pediatric and adult patients aged 2 months and older.

OZANEX, a fast, effective and safe new treatment option kills bacteria quickly offering patients the shortest course of topical antibiotic treatment.

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® products5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023CHEMICAL INDONESIA 2024INALAB 2024